Starsource Multitrade

Starsource Multitrade FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Starsource Multitrade (506365.BO) as of Oct 20, 2026 is 89.60 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -82.52 % — a change of -208.58% (higher).

FCF Conversion

89.60 %

YoY

-208.58%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Starsource Multitrade is 2026 89.60 % . FCF Conversion Rate (FCF/EBITDA) of Starsource Multitrade was 2025 -82.52 % . It decreases by -208.58% higher compared to the previous year.

The Starsource Multitrade FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
-393.76 INR
Jan 1, 2020
1,163.98 INR
Jan 1, 2021
-163.29 INR
Jan 1, 2022
-58.68 INR
Jan 1, 2023
-1,444.80 INR
Jan 1, 2024
60.28 INR
Jan 1, 2025
-82.52 INR
Jan 1, 2026
89.60 INR
The Starsource Multitrade FCF Conversion history
YEARFCF ConversionYoY
89.60 %-208.58%
-82.52 %-236.88%
60.28 %-104.17%
-1,444.80 %+2,362.13%
-58.68 %-64.06%
-163.29 %-114.03%
1,163.98 %-395.60%
-393.76 %-76.15%
-1,650.86 %-1,306.32%
136.85 %-5.21%
144.37 %-891.23%
-18.25 %-73.42%
-68.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

FCF Conversion Rate (FCF/EBITDA) of Starsource Multitrade is 89.60 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Starsource Multitrade changed from -82.52 % to 89.60 %, representing a -208.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Starsource Multitrade

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Starsource Multitrade